Imalux Funding Round

9/27/2007

Venture Equity

$5,100,000

Series C

Company chairman Bill Sanford continued, "The new funding enables the Company to fully implement our well planned clinical validation of the Niris Imaging System. We have successfully placed Niris in over 20 of the world's most respected medical institutions and have gained the support of leading clinicians and researchers, principally in the field of urology with emphasis on prostate and bladder procedures. We plan to have the System in additional 10-20 significant clinical sites in the U.S. and Europe within the next 12 months. A portion of the new funding will be used to support multi-center studies in bladder cancer that are already being implemented.

Out of Business

Medical Devices & Instruments

11000 Cedar Ave 250
Cleveland, OH 44106
USA

Imalux Corporation was founded in 1996, based on a novel imaging technology, Optical Coherence Tomography (OCT). In 2000, initial seed funding enabled Imalux to start the process of commercialization.